Alibaba
BABA
Meta Platforms
META
Taiwan Semiconductor
TSM
4
Micron Technology
MU
5
Oracle
ORCL
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.